NASTAD and UCHAPS are partnering to host a webinar to provide updates of promising HIV prevention tools, discuss barriers to improve community involvement, ways health departments can address barriers, and an overview of pharmaceutical procedures, processes, restrictions, resources, and guidelines for supporting community engagement. The following topics will be covered:
CAMI Health will provide an overview of multipurpose prevention technologies and review of products in the pipeline.
HIV Vaccine Trials Network will share updates related to HIV vaccines, antibody mediated prevention research, and broadly neutralizing antibodies.
NASTAD will provide updates on long-acting antiretrovirals for pre-exposure prophylaxis.